EVO - Evotec SE reports 1H results; updates FY23 guidance
2023-08-29 03:27:45 ET
More on Evotec SE:
- Evotec: R&D, Customer Growth Not Enough To Offset Headwinds
- Bristol Myers inks licensing pact under Evotec neuroscience deal
- Evotec unit wins U.S. govt. contract to develop antibody products
- Seeking Alpha’s Quant Rating on Evotec SE
- Earnings data for Evotec SE
For further details see:
Evotec SE reports 1H results; updates FY23 guidance